Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Working Capital/Sales

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.771.545.163.901.57

What is the latest Working Capital/Sales ratio of ORCHID PHARMA ?

The latest Working Capital/Sales ratio of ORCHID PHARMA is 1.77 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.77
Mar20241.54
Mar20235.16
Mar20223.90
Mar20211.57

How is Working Capital/Sales of ORCHID PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.77
14.94
Mar2024 1.54
-70.16
Mar2023 5.16
32.31
Mar2022 3.9
148.41
Mar2021 1.57 -

Other Financial Ratios of ORCHID PHARMA


Compare Working Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹2,552.5 Cr -6.1% -22.1% -36% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-6.1%

-22.1%

-36%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses